Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M161,772Revenue $M42,237Net Margin (%)27.0Altman Z-Score3.2
Enterprise Value $M176,557EPS $4.1Operating Margin %12.5Piotroski F-Score4
P/E(ttm)14.9Beneish M-Score-2.9Pre-tax Margin (%)40.0Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %5.4Quick Ratio1.3Cash flow > EarningsN
Price/Sales4.05-y EBITDA Growth Rate %4.0Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow30.6y-y EBITDA Growth Rate %75.5ROA % (ttm)10.9Higher Current Ratio y-yN
Dividend Yield %3.1PEG3.7ROE % (ttm)23.3Less Shares Outstanding y-yY
Payout Ratio %46.0Shares Outstanding M2,825ROIC % (ttm)6.5Gross Margin Increase y-yN

Gurus Latest Trades with MRK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MRKKen Fisher 2015-06-30 Add0.02%$56.73 - $60.89
($58.76)
$ 56.99-3%Add 2.35%6,836,547
MRKVanguard Health Care Fund 2015-03-31 Add0.53%$56.06 - $63.03
($59.34)
$ 56.99-4%Add 12.04%40,096,948
MRKDodge & Cox 2015-03-31 Reduce-0.44%$56.06 - $63.03
($59.34)
$ 56.99-4%Reduce 24.30%25,448,977
MRKKahn Brothers 2015-03-31 Reduce-0.22%$56.06 - $63.03
($59.34)
$ 56.99-4%Reduce 2.18%1,029,815
MRKJoel Greenblatt 2015-03-31 Reduce-0.17%$56.06 - $63.03
($59.34)
$ 56.99-4%Reduce 35.28%676,758
MRKJames Barrow 2015-03-31 Add0.13%$56.06 - $63.03
($59.34)
$ 56.99-4%Add 7.03%24,464,116
MRKCharles Brandes 2015-03-31 Reduce-0.07%$56.06 - $63.03
($59.34)
$ 56.99-4%Reduce 3.69%2,221,791
MRKMario Gabelli 2015-03-31 Add0.01%$56.06 - $63.03
($59.34)
$ 56.99-4%Add 11.45%160,943
MRKNWQ Managers 2015-03-31 Reduce-0.01%$56.06 - $63.03
($59.34)
$ 56.99-4%Reduce 9.00%76,286
MRKKen Fisher 2015-03-31 Add$56.06 - $63.03
($59.34)
$ 56.99-4%Add 0.59%6,679,499
MRKKahn Brothers 2014-12-31 Reduce-0.54%$53.43 - $61.88
($58.42)
$ 56.99-2%Reduce 5.08%1,052,807
MRKVanguard Health Care Fund 2014-12-31 Add0.32%$53.43 - $61.88
($58.42)
$ 56.99-2%Add 7.08%35,788,048
MRKJoel Greenblatt 2014-12-31 Add0.23%$53.43 - $61.88
($58.42)
$ 56.99-2%Add 94.88%1,045,652
MRKFirst Eagle Investment 2014-12-31 Reduce-0.16%$53.43 - $61.88
($58.42)
$ 56.99-2%Reduce 99.16%9,050
MRKJoel Greenblatt 2014-09-30 Add0.24%$55.64 - $61.18
($58.89)
$ 56.99-3%Add 323.00%536,550
MRKFirst Eagle Investment 2014-09-30 Reduce-0.1%$55.64 - $61.18
($58.89)
$ 56.99-3%Reduce 38.25%1,083,826
MRKKahn Brothers 2014-09-30 Reduce-0.09%$55.64 - $61.18
($58.85)
$ 56.99-3%Reduce 0.97%1,109,189
MRKCharles Brandes 2014-09-30 Reduce-0.08%$55.64 - $61.18
($58.85)
$ 56.99-3%Reduce 4.69%2,320,288
MRKVanguard Health Care Fund 2014-09-30 Reduce-0.07%$55.64 - $61.18
($58.85)
$ 56.99-3%Reduce 1.38%33,420,748
MRKRobert Bruce 2014-09-30 Add0.06%$55.64 - $61.18
($58.85)
$ 56.99-3%Add 1.34%265,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MRK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MRK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Schechter Adam HEVP & Pres-Global Human Health 2015-05-11Sell10,634$60.44-5.71view
Gerberding Julie L.EVP Strat Comm, Gl Pub Policy 2015-05-08Sell38,368$60.99-6.56view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-05-04Sell56,064$60.2-5.33view
Holston Michael JEVP, Legal 2015-04-29Sell95,624$59.84-4.76view
Kuhlik Bruce NExe V-P & Gen Counsel 2015-04-29Sell156,902$59.82-4.73view
FRAZIER KENNETH CChairman, President & CEO 2015-02-18Sell5,164$58.67-2.86view
Deese Willie AExe V-P & Pres. MMD 2015-02-11Sell135,864$58.56-2.68view
WENDELL PETER CDirector 2015-02-09Sell5,000$58.76-3.01view
Schechter Adam HEVP & Pres-Global Human Health 2015-01-15Sell74,200$62.48-8.79view
FRAZIER KENNETH CChairman, President & CEO 2015-01-09Sell8,840$62.47-8.77view

Press Releases about MRK :

Quarterly/Annual Reports about MRK:

    News about MRK:

    Articles On GuruFocus.com
    Manning & Napier Advisors' Most Weighted Trades in Q2 2015 Jul 10 2015 
    Intrexon Corp is expanding his business Jun 25 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Abbvie Inc. Dividend Stock Analysis May 26 2015 
    Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 
    Risk & Reward with Gilead Sciences Inc. (GILD) May 14 2015 
    Vanguard Adds to Four of Its Largest Stakes May 04 2015 
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    Robert Bruce's Top Growth Stocks Apr 13 2015 

    More From Other Websites
    Merck beats Q2 earnings estimates as sales fall Jul 28 2015
    Pfizer beats, Dupont warns; UPS hurt by dollar; Ford soars Jul 28 2015
    Cramer: Hats off to China Jul 28 2015
    Merck (MRK) Tops on Q2 Earnings & Revenues - Tale of the Tape Jul 28 2015
    Early movers: F, PFE, MRK, DD, WYN, DHI & more Jul 28 2015
    Merck tops Street 2Q forecasts despite lower sales, profit Jul 28 2015
    Merck tops Street 2Q forecasts despite lower sales, profit Jul 28 2015
    Pfizer, Merck 2Q Profits Beat Estimates Jul 28 2015
    Wall Street's bounce back; Yellen in spotlight; Trump's $21M penthouse deal Jul 28 2015
    Merck raises forecast on strong sales of diabetes, cancer drugs Jul 28 2015
    Merck & Co Inc Earnings Call scheduled for 8:00 am ET today Jul 28 2015
    Merck Earnings Top Views Amid Cost Cuts Jul 28 2015
    Dissecting big pharma's numbers: Pro Jul 28 2015
    Merck beats profit expectations and raises its outlook Jul 28 2015
    Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics Jul 28 2015
    Merck Announces Second-Quarter 2015 Financial Results Jul 28 2015
    Merck tops Street 2Q forecasts Jul 28 2015
    Merck tops Street 2Q forecasts Jul 28 2015
    Merck Second-Quarter Profit Beats Estimates, Target Raised Jul 28 2015
    Strong dollar weighs on Merck revenue Jul 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK